OrbusNeich Medical Group Holdings (HKSE:06929) 3-Year Revenue Growth Rate : 20.30% (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is OrbusNeich Medical Group Holdings 3-Year Revenue Growth Rate?

OrbusNeich Medical Group Holdings's Revenue per Share for the six months ended in Jun. 2024 was HK$0.75.

During the past 12 months, OrbusNeich Medical Group Holdings's average Revenue per Share Growth Rate was 1.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 20.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 6 years, the highest 3-Year average Revenue per Share Growth Rate of OrbusNeich Medical Group Holdings was 20.30% per year. The lowest was 14.80% per year. And the median was 17.55% per year.

Competitive Comparison of OrbusNeich Medical Group Holdings's 3-Year Revenue Growth Rate

For the Medical Instruments & Supplies subindustry, OrbusNeich Medical Group Holdings's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OrbusNeich Medical Group Holdings's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OrbusNeich Medical Group Holdings's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where OrbusNeich Medical Group Holdings's 3-Year Revenue Growth Rate falls into.

OrbusNeich Medical Group Holdings 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

OrbusNeich Medical Group Holdings (HKSE:06929) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

OrbusNeich Medical Group Holdings 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of OrbusNeich Medical Group Holdings's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

OrbusNeich Medical Group Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrbusNeich Medical Group Holdings Ltd (HKSE:06929) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

3rd Floor, Building 20E, Units 303 and 305, Hong Kong Science Park, Shatin New Town, Hong Kong, HKG

Website

https://www.orbusneich.com

OrbusNeich Medical Group Holdings Ltd is a China-based medical device maker of endovascular interventional instruments with majority reach. It launched its first research base in 2001 and was listed on the Hong Kong Exchange in 2022. As of 2023, OrbusNeich's majority revenue segment by geography is Japan with 24.7% of total revenue followed by Europe, the Middle East, and Africa, with 23.6% of total revenue. The Asia-Pacific region and the United States make up the balance. Its product segment is coronary interventional medical devices, such as scoring balloons, non-compliant balloons, or stents, together representing 82.7% of its total revenue.

Executives

Harmony Tree Limited	2101 Beneficial owner
Shenzhen Capital Group Co., Ltd.	2201 Interest of corporation controlled by you
Suzhou Red Earth Yeju Investment Ltd.	2101 Beneficial owner
Chien David	2201 Interest of corporation controlled by you
Lau Kwai Ching Denise	2201 Interest of corporation controlled by you
Shen Chuang Tou Zhi Zao Ye Zhuan Xing Sheng Ji Xin Cai Liao Ji Jin You Xian He Huo	2201 Interest of corporation controlled by you
Shen Chuang Tou Hong Tu Si Mu Gu Quan Tou Zi Ji Jin Guan Li Shen Zhen You Xian Gong Si	2201 Interest of corporation controlled by you
Su Zhou Hong Tu Ye Ju Chuang Ye Tou Zi He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you

OrbusNeich Medical Group Holdings Headlines

No Headlines